The clinical cases are to gain an understanding of the diagnosis and management of some of the rarer and more unusual dermatology conditions and unusual presentations of common dermatological problems.
Benefits of attending:
For those attending in person, the clinical cases will be followed by a drinks reception to facilitate networking.
Book to attend this event in person or virtually. To view the rates and agenda, please select your preference below.
Attendance criteria
You can only attend this meeting if you hold a Consultant or training post in dermatology. You must bring ID with you to show this. Exceptions are made for those who are Section members (by completing an additional application form) who have made significant contributions to dermatology and are of good standing in the profession.
This event will be recorded* and all registered delegates will be able to access the recording for 60 days after. The link will be distributed 3 days after the event takes place.
Follow us on:
Facebook
Instagram
LinkedIn
Twitter
YouTube
The Dermatology Section would like to thank our Annual Sponsors AbbVie, Almirall Ltd, Bristol Myers Squibb, Eucerin, Incyte, La Roche-Posay & Cerave, Lilly, Pfizer, Regeneron, Sanofi and UCB Pharma Ltd for their valued support of the 2024 to 2025 Academic Programme. We would also like to thank our sponsors Aveeno®, Johnson & Johnson Innovative Medicine, LEO Pharma and Novartis for their support of this meeting.
Please note that none of the companies listed has had any influence or involvement over the agenda, content or organisation of the meetings.
Dr Anshoo Sahota, President, Dermatology Section, Royal Society of Medicine
Dr Callum Verran, Specialty Trainee Year 3, Brighton and Sussex University Hospitals NHS Trust on behalf of Dr Deirdre O’Callaghan, Consultant Dermatologist, Brighton and Sussex University Hospitals NHS Trust
Dr Hannah Binns, Specialty Trainee Year 3, Royal Berkshire NHS Foundation Trust on behalf of Dr Patrick Bryan Consultant Dermatologist, Royal Berkshire NHS Foundation Trust
Dr Louise St Aimee, Dermatology Clinical Fellow, University Hospitals Bristol NHS Foundation Trust on behalf of Dr Lucy Webber, Consultant Dermatologist, Dermatology North Bristol NHS Trust and Dr Amrit Darvay, Consultant Dermatologist, Dermatology North Bristol NHS Trust
Dr James Dickens, Dermatology Clinical Fellow, Bristol Royal Infirmary on behalf of Dr Aparna Sinha, Consultant Dermatologist, Bristol Royal Infirmary, Dr Giles Dunnill, Consultant Dermatologist, Bristol Royal Infirmary, Dr Natalie King, Consultant Dermatologist, Bristol Royal Infirmary, and Dr Jonathan Potts, Consultant Histopathologist, North Bristol NHS Foundation Trust
Live stream: Sponsored industry presentation by Incyte
Opzelura: Now you can put vitiligo in the spotlight video
Live stream: Sponsored industry presentation by Almirall Ltd
EBGLYSS ▼(lebrikiziumab) clinical data: What do the trials show
Dr Saman Zaman, Speciality Trainee Year 5, University College London Hospitals on behalf of Dr Ian Proctor, Dr Yurina Miki, Dr Barbara Carey, Prof. Edward Odell, Dr Ben Uttenthal, Dr Eduardo Calonje, Dr Jessica Manson, and Prof. CB Bunker, University College London Hospitals
Dr Amy Long, Dermatology Registrar, Beaumont Hospital Dublin on behalf of Dr Karen Eustace, Consultant Dermatologist, Beaumont Hospital Dublin
Dr YiXuan Goh, Dermatology Registrar, South Infirmary Victoria University Hospital on behalf of Dr John Bourke, Consultant Dermatologist, South Infirmary Victoria University Hospital
Dr Charlotte Velik, Australian Dermatology Clinical Fellow, Oxford University Hospitals NHS Trust on behalf of Dr Tess McPherson, Consultant Dermatologist, Oxford University Hospitals NHS Trust
Dr Anshoo Sahota, President, Dermatology Section, Royal Society of Medicine
Dr Callum Verran, Specialty Trainee Year 3, Brighton and Sussex University Hospitals NHS Trust on behalf of Dr Deirdre O’Callaghan, Consultant Dermatologist, Brighton and Sussex University Hospitals NHS Trust
Dr Hannah Binns, Specialty Trainee Year 3, Royal Berkshire NHS Foundation Trust on behalf of Dr Patrick Bryan Consultant Dermatologist, Royal Berkshire NHS Foundation Trust
Dr Louise St Aimee, Dermatology Clinical Fellow, University Hospitals Bristol NHS Foundation Trust on behalf of Dr Lucy Webber, Consultant Dermatologist, Dermatology North Bristol NHS Trust and Dr Amrit Darvay, Consultant Dermatologist, Dermatology North Bristol NHS Trust
Dr James Dickens, Dermatology Clinical Fellow, Bristol Royal Infirmary on behalf of Dr Aparna Sinha, Consultant Dermatologist, Bristol Royal Infirmary, Dr Giles Dunnill, Consultant Dermatologist, Bristol Royal Infirmary, Dr Natalie King, Consultant Dermatologist, Bristol Royal Infirmary, and Dr Jonathan Potts, Consultant Histopathologist, North Bristol NHS Foundation Trust
Live stream: Sponsored industry presentation by Incyte
Opzelura: Now you can put vitiligo in the spotlight video
Live stream: Sponsored industry presentation by Almirall Ltd
EBGLYSS ▼(lebrikiziumab) clinical data: What do the trials show
Dr Saman Zaman, Speciality Trainee Year 5, University College London Hospitals on behalf of Dr Ian Proctor, Dr Yurina Miki, Dr Barbara Carey, Prof. Edward Odell, Dr Ben Uttenthal, Dr Eduardo Calonje, Dr Jessica Manson, and Prof. CB Bunker, University College London Hospitals
Dr Amy Long, Dermatology Registrar, Beaumont Hospital Dublin on behalf of Dr Karen Eustace, Consultant Dermatologist, Beaumont Hospital Dublin
Dr YiXuan Goh, Dermatology Registrar, South Infirmary Victoria University Hospital on behalf of Dr John Bourke, Consultant Dermatologist, South Infirmary Victoria University Hospital
Dr Charlotte Velik, Australian Dermatology Clinical Fellow, Oxford University Hospitals NHS Trust on behalf of Dr Tess McPherson, Consultant Dermatologist, Oxford University Hospitals NHS Trust
Royal Society of Medicine, 1 Wimpole St, Marylebone, London, W1G 0AE, United Kingdom
Registration for this event will close at 1:00am on Wednesday 20 November 2024. Late registrations will not be accepted.
The agenda is subject to change at any time
If the event is recorded, we are only able to share presentations that we have received permission to share. There is no guarantee that all sessions will be available after the event, this is at the presenter’s and RSM discretion.
All views expressed at this event are of the speakers themselves and not of the Royal Society of Medicine, nor the speaker's organisations.
This event will be recorded and stored by the Royal Society of Medicine and may be distributed in future on various internet channels.
